AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Create a link to this page

Copy and paste this link tag into your Web page or blog:

<a href="http://www.accessmylibrary.com/coms2/summary_0286-11196322_ITM" title="Facts and information about Study shows new type of drug helps intestinal cancer patients with no more options.">Study shows new type of drug helps intestinal cancer patients with no more options.</a>

Close Set up an RSS feed that alerts you when new articles from The America's Intelligence Wire are available.

Frequently asked questions about RSS feeds

Study shows new type of drug helps intestinal cancer patients with no more options.

The America's Intelligence Wire

| November 03, 2005 | COPYRIGHT 2003 Financial Times Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

(From AP Worldstream)

Byline: EMMA ROSS

A new anti-cancer medicine has been shown to dramatically delay the progression of the disease in patients with a rare type of intestinal cancer who have run out of options because their tumors have outsmarted even the latest high-tech drug.

The pill, Sutent, is one of the first in a new class of cancer drugs that target multiple tumor activities at once. Doctors are hopeful the drugs will usher in a new era where combinations of finely targeted drugs can dramatically improve the prognosis of cancer patients in a similar way that triple-combination therapy has revolutionized HIV treatment.

…

View articles courtesy of your local library

Related articles from newspapers, magazines, journals, and more


Cancer patients will continue to receive Sutent.: News wire article from: Europe Intelligence Wire August 8, 2008 700+ words
...newly referred kidney cancer patients will continue to receive...Nice) has turned down Sutent, Avastin, Nexavar...currently receiving Sutent for renal carcinoma...oncologists who see new kidney cancer patients and consider that they...clinical benefit from Sutent can also ...


Pfizer's Sutent is Recommended as First-Line Treatment for Kidney Cancer...: Press release article from: Business Wire February 4, 2009 700+ words
...survival of patients treated with Sutent exceeded two years. In September...recommendation regarding the coverage of Sutent, and makes Sutent the only one of the four medicines...important step forward for kidney cancer patients and also for physicians in the...


Sutent cleared for UK kidney cancer patients.: Newspaper article from: Pharma Marketletter March 30, 2009 700+ words
...use of global drug behemoth Pfizer's Sutent (sunitinib) for the first-line treatment...The NICE said the decision to review Sutent separately from Swiss major Roche's...the appeal process. Pfizer argued that Sutent is the only treatment to offer survival...


Pfizer applies for FDA approval of cancer drug Sutent.: News wire article from: The America's Intelligence Wire August 10, 2005 700+ words
...its application seeks to have Sutent approved as a treatment for patients...clinical trials, the company tested Sutent on cancer patients whose tumors had become resistant...Pfizer added that it's testing Sutent in the treatment of breast, lung...


UPDATE 1-Pfizer applies for FDA approval of cancer drug Sutent.: News wire article from: The America's Intelligence Wire August 10, 2005 700+ words
...its application seeks to have Sutent approved as a treatment for patients...clinical trials, the company tested Sutent on cancer patients whose tumors had become resistant...Pfizer added that it's testing Sutent in the treatment of breast, lung...


Pfizer submits MAA to EMEA for new Sutent.: Newspaper article from: Pharma Marketletter August 21, 2006 700+ words
...Medicines Agency (EMEA) for Sutent (sunitinib malate) as...conditional authorization for Sutent as a treatment for cytokine...involving 169 advanced kidney cancer patients for whom standard therapies had failed. Sutent-treated patients experienced...


Pfizer's Sutent is the key player in new targeted therapy era for kidney cancer.: Newspaper article from: Pharma Marketletter April 6, 2009 700+ words
...crossing over from IFN-a to Sutent, median overall survival in Sutent-treated patients was double...clinicians about how to exploit Sutent's full potential to further benefit advanced kidney cancer patients. Martin Gore of the Royal Marsden...


PFIZER'S SUTENT RECOMMENDED AS 1ST-LINE TRTMNT FOR KIDNEY CANCER.: News wire article from: AsiaPulse News February 5, 2009 700+ words
...NYSE) Pfizer's Sutent is Recommended as...Treatment for Kidney Cancer Patients by British Health...regarding the coverage of Sutent, and makes Sutent the only one of the...forward for kidney cancer patients and also for physicians...


New data show Pfizer's Sutent/SU11248 (sunitinib malate) extends overall...: News wire article from: Asia Africa Intelligence Wire May 14, 2005 700+ words
...benefited from treatment with Sutent. Preliminary results from a Phase II study of Sutent in patients with inoperable...Phase II study evaluating Sutent in the treatment of patients...address unmet medical needs in cancer patients.


Pfizer Discontinues Phase 3 Trial of Sutent[R] in Metastatic Colorectal Cancer.: Press release article from: Business Wire June 30, 2009 700+ words
...patients receiving treatment with Sutent. The most common adverse reactions...bleeding. For more information on Sutent and Pfizer Oncology, including...prescribing information for Sutent (sunitinib malate), please...innovative treatment options for cancer patients worldwide. Our robust pipel

For more facts and information, see all results

The AccessMyLibrary advertising network includes: